首页> 外文期刊>British Medical Journal >Effects of legislation restricting pack sizes of paracetamol and salicylate on self poisoning in the United Kingdom: before and after study
【24h】

Effects of legislation restricting pack sizes of paracetamol and salicylate on self poisoning in the United Kingdom: before and after study

机译:立法限制对乙酰氨基酚和水杨酸酯的包装大小对英国自毒的影响:研究前后

获取原文
获取原文并翻译 | 示例
       

摘要

Objective To evaluate the effects on suicidal behaviour of legislation limiting the size of packs of paracetamol and salicylates sold over the counter. Setting UK population, with detailed monitoring of data from five liver units and seven general hospitals, between September 1996 and September 1999. Subjects People who died by suicidal or accidental overdose with paracetamol or salicylates, or who died of undetermined causes; patients admitted to liver units with hepatic paracetamol poisoning; patients presenting to general hospitals with self poisoning after taking paracetamol or salicylates. Main outcome measures Mortality from paracetamol or salicylate overdose; numbers of patients referred to liver units or listed for liver transplant; numbers of transplantations; numbers of overdoses and tablets taken; blood concentrations of the drugs; prothrombin times; sales to pharmacies and other outlets of paracetamol and salicylates. Results Numbers of tablets per pack of paracetamol and salicylates decreased markedly in the year after the change in legislation on 16 September 1998. The annual number of deaths from paracetamol poisoning decreased by 21% (95% confidence interval 5% to 34%) and the number from salicylates decreased by 48% (11% to 70%). Liver transplant rates after paracetamol poisoning decreased by 66% (55% to 74%). The rate of non-fatal self poisoning with paracetamol in any form decreased by 11% (5% to 16%), mainly because of a 15% (8% to 21%) reduction in overdoses of paracetamol in non-compound form. The average number of tablets taken in paracetamol overdoses decreased by 7% (0% to 12%), and the proportion involving > 32 tablets decreased by 17% (4% to 28%). The average number of tablets taken in salicylate overdoses did not decrease, but 34% fewer (2% to 56%) salicylate overdoses involved > 32 tablets. After the legislation mean blood concentrations of salicylates after overdose decreased, as did prothrombin times; mean blood concentrations of paracetamol did not change. Conclusion Legislation restricting pack sizes of paracetamol and salicylates in the United Kingdom has had substantial beneficial effects on mortality and morbidity associated with self poisoning using these drugs.
机译:目的评估立法对限制在柜台上出售的扑热息痛和水杨酸酯包装的大小对自杀行为的影响。在1996年9月至1999年9月之间,对英国的人口进行详细监测,并收集了来自五个肝脏部门和七家综合医院的数据。对象死于因对乙酰氨基酚或水杨酸酯导致的自杀性或意外过量死亡或死因不明的人;入肝对乙酰氨基酚中毒的肝病患者;服用扑热息痛或水杨酸酯后到综合医院就诊的中毒患者。主要结局指标过量服用扑热息痛或水杨酸盐导致的死亡率。转诊到肝病单位或列出进行肝移植的患者人数移植数量;服用过量和药片的数量;药物的血液浓度;凝血酶原时间;销售给药房和扑热息痛和水杨酸酯的其他销售点。结果1998年9月16日立法变更后的一年中,每包扑热息痛和水杨酸酯的片剂数量显着下降。每年扑热息痛中毒死亡人数下降21%(95%置信区间5%至34%),水杨酸盐的数量减少了48%(从11%降至70%)。扑热息痛中毒后的肝移植率降低了66%(从55%降至74%)。扑热息痛以任何形式发生的非致命性自中毒率降低了11%(5%至16%),这主要是因为非化合物形式的扑热息痛的过量用药减少了15%(8%至21%)。服用扑热息痛过量的药片的平均数量减少了7%(0%至12%),> 32片药片的比例减少了17%(4%至28%)。水杨酸过量服用的平均片剂数量没有减少,但水杨酸过量服用的> 32片减少了34%(2%至56%)。在立法之后,过量使用后水杨酸盐的平均血药浓度降低,凝血酶原时间也降低;扑热息痛的平均血药浓度没有变化。结论在英国,立法限制对乙酰氨基酚和水杨酸酯的包装大小,对使用这些药物引起的自毒中毒的死亡率和发病率具有实质性的有益影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号